StockWatch
·
Q1 FY-2027 RESULTS · DEEPAKFERT

DFPCL Q1 profits double: consolidated PAT +101% YoY to ₹490 Cr, record 26% EBITDA margin

PAT +100.95% YoY · revenue +22.47% · margins expanding · beat vs street

Q1 FY27 resultsDEEPAKFERTDEEPAK FERTILISERS & PETROCHEMICALS CORPORATION LTD.30 Jul 2026 · 3 min read
Revenue

₹3,256.26 Cr

+22.47% YoY

PAT (consolidated)

₹490.04 Cr

+100.95% YoY

Net margin

15.02%

+5.9pp YoY

EPS

₹38.82

Deepak Fertilisers delivered its strongest-ever quarter on a consolidated basis, with net profit more than doubling to ₹490 Cr (+101% YoY, +252% QoQ) on revenue of ₹3,256 Cr (+22% YoY, +8% QoQ). The print was powered by margin, not just volume: operating EBITDA hit a record ₹845 Cr (+65% YoY) and EBITDA margin expanded to 26.0% from 19.3% a year ago, while PAT margin widened to 15.0% from 9.1%. The lever was pricing and cost — stronger realisations across Ammonia, TAN, Nitric Acid and IPA, plus the commencement of Equinor LNG supplies stabilising input costs — which offset a 12% YoY drop in TAN sales volumes caused by PESO-portal dispatch disruptions and RGP shortages in IPA.

The scoreboard

Q1 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q1 FY-2027QoQYoY
Revenue₹3,256.26 Cr+8.1%+22.5%
Expenses₹2,610.84 Cr-8.6%+11.7%
PAT₹490.04 Cr+251.63%+100.95%
Net margin15.02%+10.4pp+5.9pp
EPS₹38.82+251.6%+101.6%

The critical nuance is basis divergence: standalone PAT actually fell ~21% YoY to ₹68 Cr on an 11% revenue decline, so the entire group upswing sits in the subsidiaries — Mahadhan AgriTech (mining chemicals/TAN) and the Platinum Blasting explosives arm — where four subsidiaries alone contributed ₹217 Cr of net profit. Readers seeing the standalone number elsewhere should not mistake it for weakness; the consolidated entity is where DFPCL's integrated LNG-to-ammonia-to-mining-chemicals chain now earns.

₹
1,165.451,303.531,441.61,579.671,717.751,611.804-2705-1906-1107-0607-2807-30Q1 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹1,611.8, up 0.4% over the past month of trading.

₹ Cr
0182.95365.9548.84277.86Q4 FY25rev ₹2,667 Cr243.86Q1 FY26rev ₹2,659 Cr214.02Q2 FY26rev ₹3,006 Cr141.49Q3 FY26rev ₹2,830 Cr139.39Q4 FY26rev ₹3,011 Cr490.04Q1 FY27rev ₹3,256 Cr
Quarterly consolidated PAT, ₹ Crore

For context: this is the highest quarterly PAT in the last 6 quarters on our records; revenue is at a 6-quarter high.

Beyond the headline

What the summary numbers don't show

No exceptional items either period — the doubling is fully underlying, not one-off aided

What management guided (4 FY-2026 call)
Management is confident about a progressively stronger performance driven by new capacities coming online, including the Gopalpur TAN and Dahej nitric acid projects, expected in Q2 FY '27. They anticipate improved quality of earnings, supported by tightening global supply conditions, enhanced cost visibility and stabil

— This quarter: beat

Against its own guidance the quarter is a clear beat. On the Q4 FY26 concall management had framed a 'progressively stronger' FY27 driven by the Gopalpur TAN and Dahej Nitric Acid capacities due Q2 — yet DFPCL delivered record EBITDA and doubled PAT in Q1 before those projects contribute a rupee (Gopalpur ~96% complete, Dahej ~93%, commercial start now end-Q2, profit from Q3). Street had modelled only ~15-20% FY27 PAT growth, so a +101% Q1 print runs well ahead of consensus. Balance-sheet discipline held alongside the earnings jump — net debt fell to ₹4,719 Cr and net-debt/EBITDA improved to 1.4x. CMD S.C. Mehta called it 'an important milestone… highest ever EBITDA and PAT,' crediting the integrated value chain and the shift toward specialty/B2C products (43% of Crop Nutrition revenue, 17% of mining-chemicals sales), and the numbers back that framing.

  • W1

    Gopalpur TAN (~96%) and Dahej Nitric Acid (~93%) commissioning end-Q2, profit contribution from Q3 — the next leg of growth guidance to verify

  • W2

    TAN volume recovery from the 12% YoY PESO-portal decline and IPA recovery on improved propylene availability

  • W3

    Sustainability of 26% EBITDA margin as realisation tailwinds and FGAN pricing normalise; fertiliser subsidy alignment amid delayed monsoon

In ₹ Lakhs, converted to Cr. No exceptional items either side. Consolidated PAT +101% YoY but standalone PAT -21% YoY (68.3 vs 86.9 Cr) — group gains sit in subsidiaries; four unreviewed-by-principal subsidiaries alone posted ₹217 Cr PAT. Consol arithmetic ties: 3256.26+5.95=3262.21 income; 651.37-161.33=490.04 PAT. No minority interest impact (all PAT to owners).

Informational and educational content only. Not investment advice.